CClinicalTrials.gg
CompletedNCT02018848Updated Nov 13, 2014

Internet-delivered Attention Training for Obsessive-Compulsive Disorder

An interventional study of Attention Training Program in Obsessive-Compulsive Disorder, sponsored by Humboldt-Universität zu Berlin. Completed at 1 site in Germany. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2014-11-13.

Sponsored by Humboldt-Universität zu Berlin · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this study is to investigate an attention training program for participants with Obsessive-Compulsive Disorder. The attention training consists of a modified dot probe task with picture stimuli related to washing and checking paired with neutral pictures.

Participants are randomly assigned to an experimental and a placebo-control group. After a minimum of 4 weeks of attention training we expect to find differences between participants of the experimental and the control group in terms of attention bias, OCD symptoms, anxiety and depression.

02

Conditions studied

  • Obsessive-Compulsive Disorder

Keywords

  • Obsessive-Compulsive Disorder
  • Attention Training
  • Attention Bias Modification
  • Dot-Probe Task
  • Randomized Controlled Trial
  • Online Treatment
  • Washing
  • Checking
03

In context

Compulsive Personality Disorder

367 studies on the registry are indexed under Compulsive Personality Disorder; 67 are open to participants now.

This study's enrollment of 108 is above the median of 37 across 306 interventional studies indexed under Compulsive Personality Disorder.

Browse Compulsive Personality Disorder studies →

Lead sponsor

Humboldt-Universität zu Berlin is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of primary OCD according to OCI-R self report (cut-off >=18)

Exclusion criteria

Exclusion Criteria:

  • suicidal
  • substance abuse or addiction
  • psychotic symptoms
  • visual impairment if not compensated with optical aid

Current treatment is not an exclusion criterion, but data on treatment status (current psycho- or pharmacotherapy for OCD) will enter our statistical analyses.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
108 participants (actual)

Study arms

  • Placebo comparator
    Attention Training Placebo

    Same procedure, stimulus material, frequency and duration as in experimental group. The only difference: In the placebo group the probe randomly appears at one of the two locations on the screen so as not to train attention in any direction. Thus, the placebo training sessions are identical to the bias assessment sessions.

  • Experimental
    Attention Training Program

    The Attention Training consists of a modified dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented for 500 ms on a computer screen. Next, a probe appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard. One training session takes approximately 10 minutes in which 160 stimulus pairs are shown. In the experimental group the probe always appears at the location of the neutral picture so as to train attention away from OCD-relevant stimuli. Participants are asked to complete at least 2 training sessions per week over a period of 5 weeks. The first and last session are bias assessment sessions (see outcome measures), but participants stay blind to this.

    Behavioral: Attention Training Program

Interventions

  • BehavioralAttention Training Program

    Also known as: ATP, Attention Bias Modification Treatment, ABMT, Bias Modification, Attentional Training

06

What researchers measure

Primary outcomes

  1. Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T1

    The Y-BOCS-SRS measures severity of OCD symptoms.

    Time frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set)

  2. Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T2

    The Y-BOCS-SRS measures severity of OCD symptoms.

    Time frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)

  3. Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T3

    The Y-BOCS-SRS measures severity of OCD symptoms.

    Time frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)

Secondary outcomes

  1. Obsessive-Compulsive Inventory-Revised (OCI-R) T1

    The OCI-R measures severity of OCD symptoms.

    Time frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set)

  2. Obsessive-Compulsive Inventory-Revised (OCI-R) T2

    The OCI-R measures severity of OCD symptoms.

    Time frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)

  3. Obsessive-Compulsive Inventory-Revised (OCI-R) T3

    The OCI-R measures severity of OCD symptoms.

    Time frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)

Other outcomes

  1. Beck Anxiety Inventory (BAI) T1

    The BAI measures severity of anxiety symptoms.

    Time frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires)

  2. Beck Anxiety Inventory (BAI) T2

    The BAI measures severity of anxiety symptoms.

    Time frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)

  3. Beck Anxiety Inventory (BAI) T3

    The BAI measures severity of anxiety symptoms.

    Time frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)

  4. Beck Depression Inventory II (BDI-II) T1

    The BDI measures severity of depressive symptoms.

    Time frame: pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires)

  5. Beck Depression Inventory II (BDI-II) T2

    The BDI measures severity of depressive symptoms.

    Time frame: post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set)

  6. Beck Depression Inventory II (BDI-II) T3

    The BDI measures severity of depressive symptoms.

    Time frame: follow-up, between day 27 and 50 after T2 questionnaires (time limit set)

  7. Attention bias towards OCD-relevant stimuli at T1 measured with a dot-probe task.

    Attention bias is measured using a dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented briefly on a computer screen. Next, a probe randomly appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard. Attention bias is calculated as the mean difference in reaction times between trials in which the probe appears at the OCD-relevant location vs. trials in which it appears at the neutral location. The bias assessment session is masked as first training sessions in both groups.

    Time frame: after T1 questionnaires and pre-treatment, estimated: between day 1 and 3 after T1 questionnaires (no time limit set)

  8. Attention bias towards OCD-relevant stimuli at T2 measured with a dot-probe task.

    Attention bias is measured using a dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented briefly on a computer screen. Next, a probe randomly appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard. Attention bias is calculated as the mean difference in reaction times between trials in which the probe appears at the OCD-relevant location vs. trials in which it appears at the neutral location.

    Time frame: post-treatment, after a minimum of 8 training sessions over a time of 4 weeks, estimated: between day 1 and 4 after last training session (no time limit set)

07

Study locations

1 site
  • Humboldt-Universität zu Berlin
    Berlin, 10099, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02018848
Lead sponsor
Humboldt-Universität zu Berlin
Responsible party
Dr. Andrea Ertle (Dr. phil. Dipl. Psych., Humboldt-Universität zu Berlin) — Principal investigator
First posted
Dec 23, 2013
Start date
Oct 2013
Primary completion
Jul 2014
Completion
Jul 2014
Last update
Nov 13, 2014
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion